This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Angela Wagner, PhD
Associate Principal Scientist, Sterile & Specialty at Merck Sharpe & Dohme


Angela M. Wagner, Ph.D. is an Associate Principal Scientist in Sterile and Specialty Products at Merck Sharpe & Dohme (MSD), responsible for advancing formulation and manufacturing process development across MSD’s parenteral drug product portfolio from preclinical stages to Phase 3 development. Over her career, her research has spanned across a number of disease areas and drug modalities, including a focus in the discovery and development of specialty formulation, drug delivery, and manufacturing technologies for MSD’s oligonucleotide therapeutics pipeline. Dr. Wagner received her Ph.D. and M.S. in Chemical Engineering at the University of Texas at Austin (under the guidance of Prof. Nicholas Peppas), and received her B.S. in Chemical Engineering at the Pennsylvania State University.

Agenda Sessions

  • Drug Product Development Strategies for Oligonucleotides and Peptides

  • Terminal Sterilisation of Oligonucleotide Drug Products

    On Demand
  • Terminal Sterilisation of Oligonucleotide Drug Products

    On Demand